Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of Papulopustular Rosacea

NCT03564119 is registered in ClinicalTrials.gov with Sol-Gel Technologies, Ltd. as lead sponsor.

NCT NCT03564119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03564119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study of S5G4T-1 in the Treatment of Papulopustular Rosacea
Lead sponsor
Sol-Gel Technologies, Ltd.
Phase
Phase 3
Overall status
Completed
Start date
June 21, 2018
Completion date
June 10, 2019
Enrollment
372 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

papulopustular rosacea